Implantable Cardiac Monitors Market Is Expected To Grow At 5.79 % CAGR From 2019 To 2028

PUNE, India - Jan. 18, 2023 - PRLog -- Rise in the prevalence of cardiac arrhythmia such as atrial fibrillation and bradycardia is increased demand for the implantable cardiac monitor in the market. Rising technological advancement and growing geriatric population across the globe are drive the market. Furthermore, rise in the prevalence of stroke, adoption of and awareness about prolonged ECG monitoring of the heart rhythm, improvements in health care infrastructure and growing demand for subcutaneous implanted cardiac monitors are fuel the implantable cardiac monitor market growth. The global implantable cardiac monitors market comprises of different market segment like indication, end users and geography. The implantable cardiac monitor market based on indication include cardiac arrhythmias, Atrial fibrillation, Epilepsy, and Unexplained Falls. The cardiac arrhythmias account larges share in the market, owing to the growing prevalence of cardiovascular diseases and increased expenditure on cardiac health globally, Also, growing demand of advance technology for cardiac rhythm monitoring. Further, the implantable cardiac monitors end-user studied in the global implantable cardiac monitors market are hospital and clinics, Home settings, Ambulatory Surgical Centers. The hospital segment account largest share in the market. The global implantable cardiac monitors market is studied for key regions such as North America, Europe, Asia Pacific and Rest of the World. The North-America is likely to dominate the global implantable cardiac monitors market.

SCOPE OF THE REPORT:

• Market Sizing for Year: 2021-2028
• Base Year: 2021
• Forecast Period: 2022-2028
• Value: USD million
• Market Segment studied: indication, end users and Geography.
• Market Players and its Competitors: Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke [Philips, N.V., LivaNova PLC, Medtronic plc, Nihon Kohden corporation and Phoenix Heart Center, Astellas Pharma Inc., Sigma-Aldrich Corporation, Agilent Technologies, Reliant Heart Inc., Abiomed Inc, Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Larvik Heart Inc. and among other.          To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/11340-global-... (https://www.axiommrc.com/request-for-sample/11340-global-...)